This article explores the half-life of Rybelsus, factors influencing its pharmacokinetics, and clinical implications for safe, effective diabetes management in UK practice
The benefits of this novel component, which are accentuated in applications involving large-molecule biologics, can be seen in an improvement in the overall patient experience when delivering GLP-1 therapies
Reducing cholesterol: In the SELECT trial, the people who took semaglutide medication saw a 4.6% drop in total cholesterol, 5.3% drop in LDL (bad) cholesterol, and a 4.9% increase in HDL (good) cholesterol
Peer review Peer review information Nature Medicine thanks Jrn Schattenberg and the other, anonymous, reviewer(s) for their contribution to the peer review of this work
Sentinel is a very large data network that contains health insurance claims and patient health records that can be used to investigate safety questions about FDA-regulated products